Active specific immunotherapy
US5484596A · kind A · utility
142Cited by
13References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 1993 |
| Grant date | Jan 16, 1996 |
| Priority date | — |
| Expiry date | Nov 1, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/865
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a method of cancer therapy for treating human patients with resectable solid tumors to inhibit recurrence and formation of metastases, comprising surgically removing tumor tissue from a human cancer patient, treating the tumor tissue to obtain tumor cells, irradiating the tumor cells to be viable but non-tumorigenic, preparing a vaccine comprising about 10.sup.7 viable but non-tumorigenic tumor cells per dose and injecting the vaccine intradermally into the human patient after the patient's immune system has recovered from surgery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.